With the recent report of mutations in the calcium channel gene CACNA1A in two families with episodic ataxia type 2, we investigated a patient with nonfamilial episodic vertigo and ataxia responsive to acetazolamide for similar mutations. Singlestrand conformation polymorphism (SSCP) analysis of exo
Nonconsensus intronic mutations cause episodic ataxia
β Scribed by Jijun Wan; Janai R. Carr; Robert W. Baloh; Joanna C. Jen
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 395 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We discovered intronic mutations in two episodic ataxia type 2 (EA2) families: a fourβnucleotide GAGT deletion at IVS41+(3β6) and a single nucleotide insertion (insT) at IVS24+3. We expressed minigenes harboring the mutations in cell lines to demonstrate exon skipping from the deletion mutation and the activation of a cryptic splice donor site from the insertion mutation. The identification of these diseaseβcausing mutations expands the spectrum of EA2 mutations and emphasizes the importance of intronic sequences in regulating gene expression. Ann Neurol 2005;57:131β135
π SIMILAR VOLUMES
## Abstract Episodic ataxia type 2 (EA2) is a dominantly inherited disorder, characterized by spells of ataxia, dysarthria, vertigo, and migraines, associated with mutations in the neuronal calciumβchannel gene __CACNA1A__. Ataxic spells lasting minutes to hours are provoked by stress, exercise, or
The majority of cases involving fragile X syndrome are due to expansion of a (CGG)n trinucleotide repeat at the 5' untranslated region of the FMR-1 gene. Deletion and intragenic loss of function mutations of the FMR-1 gene also have been reported. Here, we report a C to T point mutation at the 14th